Peter Hecht
Director/Board Member at CYCLERION THERAPEUTICS, INC.
Net worth: 1 M $ as of 2024-03-30
Profile
Peter M.
Hecht was the founder of Ironwood Pharmaceuticals, Inc. (founded in 1998) where he held the title of Chief Executive Officer & Director from 1998 to 2019.
He is also the founder of Cyclerion Therapeutics, Inc. (founded in 2019) where he currently holds the title of Director.
Dr. Hecht's current job(s) include being the Chief Executive Officer at Tisento Therapeutics, Inc., a Director at Kallyope, Inc. since 2020, and a Director at Mythic Therapeutics, Inc.Dr. Hecht's former job(s) include being a Director at Microbia, Inc. and a Director at Whitehead Institute for Biomedical Research.
Dr. Hecht's education history includes undergraduate and graduate degrees from Stanford University, as well as a doctorate degree from the University of California, Berkeley.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
CYCLERION THERAPEUTICS,INC.
13.93% | 2023-12-31 | 377,457 ( 13.93% ) | 1 M $ | 2024-03-30 |
Peter Hecht active positions
| Companies | Position | Start |
|---|---|---|
| CYCLERION THERAPEUTICS, INC. | Director/Board Member | 2019-03-31 |
Kallyope, Inc.
 Kallyope, Inc. Medical/Nursing ServicesHealth Services Kallyope, Inc. engages in developing drugs and consumer products. Its specialties include biotechnology, gut-brain axis, nutrition, and pharmaceuticals. The company was founded by Thomas P. Maniatis, Charles Zuker and Richard Axel in 2014 and is headquartered in New York, NY. | Director/Board Member | 2020-02-19 |
Mythic Therapeutics, Inc.
 Mythic Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mythic Therapeutics, Inc. engages in the development of cancer therapeutics. The company was founded on June 6, 2018 and is headquartered in Waltham, MA. | Director/Board Member | - |
Tisento Therapeutics, Inc.
 Tisento Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tisento Therapeutics, Inc. develops medicines to treat diseases. The CEO of the American company is Peter M. Hecht. | Chief Executive Officer | - |
Former positions of Peter Hecht
| Companies | Position | End |
|---|---|---|
| IRONWOOD PHARMACEUTICALS, INC. | Founder | 2019-03-31 |
Whitehead Institute for Biomedical Research
 Whitehead Institute for Biomedical Research Miscellaneous Commercial ServicesCommercial Services Whitehead Institute for Biomedical Research provides research and technology services. Its services include biomedical, genomics, and genetics for students. The company was founded by Edwin C. Whitehead in 1982 and is headquartered in Cambridge, MA. | Director/Board Member | - |
Microbia, Inc.
 Microbia, Inc. Pharmaceuticals: MajorHealth Technology Microbia, Inc. engages in the development of microbial manufacturing technologies for the production of chemicals from renewable raw materials. The company is headquartered in DE. | Director/Board Member | - |
Training of Peter Hecht
| Stanford University | Graduate Degree |
| University of California, Berkeley | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| IRONWOOD PHARMACEUTICALS, INC. | Health Technology |
| CYCLERION THERAPEUTICS, INC. | Health Technology |
| Private companies | 5 |
|---|---|
Microbia, Inc.
Microbia, Inc. Pharmaceuticals: MajorHealth Technology Microbia, Inc. engages in the development of microbial manufacturing technologies for the production of chemicals from renewable raw materials. The company is headquartered in DE. | Health Technology |
Whitehead Institute for Biomedical Research
Whitehead Institute for Biomedical Research Miscellaneous Commercial ServicesCommercial Services Whitehead Institute for Biomedical Research provides research and technology services. Its services include biomedical, genomics, and genetics for students. The company was founded by Edwin C. Whitehead in 1982 and is headquartered in Cambridge, MA. | Commercial Services |
Kallyope, Inc.
Kallyope, Inc. Medical/Nursing ServicesHealth Services Kallyope, Inc. engages in developing drugs and consumer products. Its specialties include biotechnology, gut-brain axis, nutrition, and pharmaceuticals. The company was founded by Thomas P. Maniatis, Charles Zuker and Richard Axel in 2014 and is headquartered in New York, NY. | Health Services |
Mythic Therapeutics, Inc.
Mythic Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mythic Therapeutics, Inc. engages in the development of cancer therapeutics. The company was founded on June 6, 2018 and is headquartered in Waltham, MA. | Health Technology |
Tisento Therapeutics, Inc.
Tisento Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tisento Therapeutics, Inc. develops medicines to treat diseases. The CEO of the American company is Peter M. Hecht. | Health Technology |
- Stock Market
- Insiders
- Peter Hecht
